戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ld be used in patients with mild-to-moderate reactive airway disease.
2 is of RSV infection and its association with reactive airway disease.
3 ry effects in patients with mild to moderate reactive airway disease.
4 withheld from patients with mild to moderate reactive airway disease.
5 neumonia, and are linked to asthma and other reactive airway diseases.
6 equired for the development of ozone-induced reactive airways disease.
7  322 (52%) of 614 had a history of asthma or reactive airway disease; 200 (66%) of 304 patients with
8 icella than were vaccinated children without reactive airway diseases (95% CI, 2.4-21.3).
9 wing respiratory-acquired infection, such as reactive airway disease, adult-onset asthma and potentia
10 o ameliorate leukotriene formation and hence reactive airway disease, and inflammation in individuals
11 wo patients had minor complications (one had reactive airway disease, and the other had a transient s
12                 The role of asthma and other reactive airway diseases as risk factors for varicella d
13 is hypothesized to play an important role in reactive airway disease/asthma, a comprehensive murine m
14 neumoniae infection and its possible role in reactive airway disease/asthma.
15  respiratory and cardiovascular diseases and reactive airway disease in sickle cell disease.
16                                     However, reactive airways disease including asthma (1.36, 0.82-2.
17 38 (51%) of 270 with no history of asthma or reactive airway disease (p=0.0004).
18 of 235 patients with no history of asthma or reactive airway disease (p=0.039).
19  of 304 patients with a history of asthma or reactive airway disease required intensive care compared
20  of 276 patients with a history of asthma or reactive airway disease required ventilator support comp
21 wheezing, and a history of underlying asthma/reactive airway disease than patients without viremia.
22 e of inhaled beta2-agonists in patients with reactive airway disease were selected.
23     Vaccinated children with asthma or other reactive airway diseases were 7.1 times more likely to h
24 y responsiveness, which are also features of reactive airway disease, were also present with pulmonar

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。